Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for RLAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -323.74M
March 31, 2026 -138.78M
December 31, 2025 -0.934M
September 30, 2025 -0.017M
June 30, 2025 -0.653M
March 31, 2025 0.00
December 31, 2024 -0.80M
September 30, 2024 -218.89M
June 30, 2024 -1.542M
March 31, 2024 -48.92M
December 31, 2023 -21.92M
September 30, 2023 -9.458M
June 30, 2023 -2.08M
March 31, 2023 -1.297M
December 31, 2022 -1.166M
Date Value
September 30, 2022 -285.86M
June 30, 2022 -1.996M
March 31, 2022 -0.883M
December 31, 2021 -384.01M
September 30, 2021 -0.902M
June 30, 2021 -1.121M
March 31, 2021 -2.055M
December 31, 2020 -425.35M
September 30, 2020 -0.442M
June 30, 2020 -0.367M
March 31, 2020 -0.351M
December 31, 2019 5.22M
September 30, 2019 -0.116M
June 30, 2019 -5.688M
March 31, 2019 -0.029M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 9.00M
TG Therapeutics, Inc. -0.085M
Karyopharm Therapeutics, Inc. 1.329M
Krystal Biotech, Inc. -15.16M
Akebia Therapeutics, Inc. -3.325M